Biotechnology International Private Fund ETP (Series 578) Notes due 2046 USD Acc
| 100,00USD | 0,00USD | 0,00% |
Nettoinventarwert (NAV)
| 100,00 USD | USD | % |
|---|
| Vortag | USD | Datum | 28.08.2026 |
Anlagepolitik
So investiert der Biotechnology International Private Fund ETP (Series 578) Notes due 2046 USD Acc: The objective of this strategy is to achieve long-term capital appreciation by investing primarily in securities that track the largest U.S. stock indexes. The strategy seeks to benefit mainly from the growth potential of leading technology companies, leveraging their innovation, market leadership, and strong financial performance.
Rating für Biotechnology International Private Fund ETP (Series 578) Notes due 2046 USD Acc
| €uro FondsNote | - |
Fonds Performance: Biotechnology International Private Fund ETP (Series 578) Notes due 2046 USD Acc
| Performance 1 Jahr | - | |
| Performance 2 Jahre | - | |
| Performance 3 Jahre | - | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |
Fundamentaldaten
| Valor | |
| ISIN | XS3447690879 |
| Name | Biotechnology International Private Fund ETP (Series 578) Notes due 2046 USD Acc |
| Fondsgesellschaft | ETPCAP2 Designated Activity Company |
| Aufgelegt in | Ireland |
| Auflagedatum | 24.07.2026 |
| Kategorie | Branchen: Andere Sektoren |
| Währung | USD |
| Volumen | |
| Depotbank | |
| Zahlstelle | |
| Fondsmanager | |
| Geschäftsjahresende | |
| Berichtsstand | 03.09.2026 |
Konditionen
| Ausgabeaufschlag | % |
| Verwaltungsgebühr | % |
| Depotbankgebühr | % |
| VL-fähig? | Nein |
| Mindestanlage | |
| Ausschüttung | Thesaurierend |